Search

    Elicera Therapeutics AB

    ELIC SE0015382080

    ICB 2010 : Health Care / Health Care
    Sweden 402 24
    SE-O Göteborg C/O Elicera Therapeutics AB
    Box 5243

    Registration Number 556966-4955

    Founded 2014

    Annual Performance 1
    2021 2022 2023 2024 2025
    -19% -29% 23% -65% 13%
    Annual Insiders Turnover, USD 2

    1 annual and historical performance metrics are recalculated on a daily basis;
    2 represents the total value of insider transactions (both buying and selling);

    Insider Activity

    Transactions: 11 Insiders: 8

    Person Price Shares Total Published Completed
    Jamal El Mosleh
    CEO
    1.00
    SEK
    50,000
    Bought
    50,000
    SEK
    26/04/2024 25/04/2024
    Jamal El Mosleh
    CEO
    1.28
    SEK
    2,687,000
    Bought
    3,439,360
    SEK
    21/03/2024 20/03/2024
    Jamal El Mosleh
    CEO
    1.28
    SEK
    2,687,000
    Sold
    3,439,360
    SEK
    21/03/2024 20/03/2024
    Jamal El Mosleh
    CEO
    4.30
    SEK
    23,000
    Bought
    98,900
    SEK
    05/07/2021 05/07/2021
    Rolf Ingvar Lennart Karlsson
    CFO
    4.30
    SEK
    23,500
    Bought
    101,050
    SEK
    05/07/2021 05/07/2021
    Margareth Jorvid
    DIR
    4.30
    SEK
    12,100
    Bought
    52,030
    SEK
    05/07/2021 05/07/2021
    Di Yu
    DIR
    4.30
    SEK
    12,100
    Bought
    52,030
    SEK
    05/07/2021 05/07/2021
    Jan Zetterberg
    DIR
    4.30
    SEK
    14,000
    Bought
    60,200
    SEK
    05/07/2021 05/07/2021
    Karin Helene Hoogendoorn
    O
    4.30
    SEK
    23,000
    Bought
    98,900
    SEK
    06/07/2021 05/07/2021
    Agneta Edberg
    CB
    4.30
    SEK
    12,791
    Bought
    55,001
    SEK
    06/07/2021 05/07/2021

    Integrated EOD Stock Data and Insider Transactions Chart

    Sign in or subscribe to include Elicera Therapeutics AB to your watchlist and receive automatic alerts for upcoming transactions.

    The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

     

    Historical Performance
    1M 3M 6M 1Y 3Y 5Y All Time
    12% 14% 5% 20% 21% -30% -68%
    Last 52W Low 52W High All-Time Low All-Time High β
    3.44 1.74 3.44 0.85 8.56 0.19
    Company Insiders
    Person / Entity Transactions Turnover, USD Average, USD First Last
    Jamal El Mosleh 4 672,830.68 168,207.67 05/07/2021 25/04/2024
    Rolf Ingvar Lennart Karlsson 1 11,820.96 11,820.96 05/07/2021 05/07/2021
    Karin Helene Hoogendoorn 1 11,569.45 11,569.45 05/07/2021 05/07/2021
    Jan Zetterberg 1 7,042.28 7,042.28 05/07/2021 05/07/2021
    Agneta Edberg 1 6,434.12 6,434.12 05/07/2021 05/07/2021
    Margareth Jorvid 1 6,086.54 6,086.54 05/07/2021 05/07/2021
    Di Yu 1 6,086.54 6,086.54 05/07/2021 05/07/2021
    Magnus Essand 1 6,086.54 6,086.54 05/07/2021 05/07/2021

    Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

    Connected Companies 3
    Name LEI ISIN Ticker
    Annexin Pharmaceuticals AB (publ) 5493000JP703HGPJEX27 SE0009664154 ANNX

    3 the firms where the current insiders have executed transactions.

    Stock Advanced Metrics
    Discipline Index 5
    Delta Correlation subscribe 🔒
    Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

    4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

    5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.